EHRs and Consumer Self-Pay Remain Top Revenue Cycle Challenges for Hospital and Health System Executives
Navigant survey conducted by HFMA shows IT budgets growing as providers focus on revenue integrity, robotic process automation, and external...
Year: 2019
Dynatronics Reports Fourth Quarter and Full Year Results for Fiscal 2019
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / September 25, 2019 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical...
Dental Hygienist at Edmonds’ Green City Dental Named Master Clinician by American Dental Hygienists’ Association
EDMONDS, WA / ACCESSWIRE / September 24, 2019 / Barbara Kempkes Tritz was awarded the Hu-Friedy/ADHA Master Clinician Award at...
CO2 GRO Inc. Announces Positive Tobacco Grow Trial Results for a Biopharma Company
TORONTO, ON / ACCESSWIRE / September 24, 2019 / Toronto based CO2GRO Inc. ("GROW") (TSX-V:GROW, OTCQB:BLONF, Frankfurt:4021) is excited to...
Canada Pharmacy Online Launches New Web Page for Pet Owners
SURREY, BC / ACCESSWIRE / September 24, 2019 / The following is a statement from Canada Pharmacy Online - Pet...
Datatron implements an ultra-high volume IBML ImageTrac scanner and SCS software to boost capacity and support future bureau growth
…New equipment to underpin NHS digital transformation projects among others…September 24, 2019 – IBML announces today that Datatron, a scanning...
Aytu BioScience Announces Addition of Natesto(R) to Leading National Pharmacy Benefit Manager’s Formulary; Natesto Added to Commercial Plans Covering Over 30 Million U.S. Lives
During the 12-month period ending June 2019, the U.S. prescription TRT market registered 6.9 million prescriptions, generating approximately $1.7 billion...
Jaguar Health to Host Investor Call October 3rd at 8 a.m. Eastern to Provide Updates Regarding Development of Mytesi for the Potential Follow-on Indication of Cancer Therapy-Related Diarrhea
SAN FRANCISCO, CA / ACCESSWIRE / September 24, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced...
Soricimed Announces Initiation of Patient Dosing for First Cohort in Investigator-Initiated Phase 1b Clinical trial of SOR-C13
TORONTO, CANADA / ACCESSWIRE / September 24, 2019 / Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company developing first-in-class, targeted cancer therapeutics,...
AIM ImmunoTech Inc. Announces a Second DoD Award, This One of $8.3 Million, to Fund Phase 2 Clinical Trial to Study Ampligen as Part of a New Treatment for Brain-Metastatic Breast Cancer at the Moffitt Cancer Center
New Ampligen-Related Strategy for Treating Advanced Breast Cancer Helps Earn 'Breakthrough Award' OCALA, FL / ACCESSWIRE / September 24, 2019...
MEDITECH Maintains Momentum in Canadian EHR Market
The Canadian EHR market leader continues growth in 2019 with additional Expanse implementations and the launch of two new toolkits...
Sexton Biotechnologies Raises $5M to Accelerate Commercialization of Cook Regentec’s Bioproduction Tools
Growth capital supports current, future innovative product development and commercialization INDIANAPOLIS--(BUSINESS WIRE)--Sexton Biotechnologies announced today that it has raised $5...
Axonics® to Exhibit its Sacral Neuromodulation System at the AUGS/IUGA Joint Scientific Meeting on September 24 – 28 in Nashville
One-year Pivotal Study Results from ARTISAN-SNM to be Presented at Plenary Session IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX),...
AIM ImmunoTech’s Ampligen Receives Clearance from FDA for Exportation to Argentina for the Treatment of Severe Chronic Fatigue Syndrome
Important Milestone to Commercial Launch in Argentina Achieved OCALA, FL / ACCESSWIRE / September 24, 2019 / AIM ImmunoTech (NYSE...
Evotec And Takeda Enter Collaboration Agreement To Discover Clinical Candidates Across Multiple Therapeutic Areas
MULTI-YEAR SMALL MOLECULE DRUG DISCOVERY COLLABORATION WITH A RISK SHARING, SUCCESS DRIVEN MODEL EVOTEC LEADS INTEGRATED PROGRAMMES WITH TAKEDA HAVING...
ESMO and Apogenix Collaborate on ‘Recurrent Glioblastoma Management: Challenges and Opportunities’ Colloquium
HEIDELBERG, GERMANY / ACCESSWIRE / September 24, 2019 / Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today...
Strong Show of Support from U.S. Businesses at ‘Think Asia, Think Hong Kong’ Los Angeles
1,500 Delegates Explore Benefits of HK as Business Platform LOS ANGELES--(BUSINESS WIRE)--“Think Asia, Think Hong Kong”, a large-scale Hong Kong...
ControlRad™ Announces First Clinical Use of ControlRad Trace Radiation Reduction Technology
Niagara Falls Memorial Medical Center First to Integrate Newly Cleared ControlRad Trace into Fluoroscopically Guided Procedures, Improving Radiation Safety for...
Sophia Hutchins Secures $3 Million in Seed Funding for LUMASOL
LOS ANGELES--(BUSINESS WIRE)--Sophia Hutchins, CEO, and founder of LUMASOL, a health technology company aimed at bringing sustainable and innovative health...
Jaguar Health Comments on FDA’s Decision to Set Packaging Limits for Anti-Diarrhea Medicine Loperamide (Imodium) to Encourage Safe Use
Mytesi® Novel Anti-Diarrheal Mechanism of Action Distinguished as Non-Opioid SAN FRANCISCO, CA / ACCESSWIRE / September 23, 2019 / Jaguar...